Ali Tavallaei was a member of the Western Medical Innovation Fellowship’s first cohort. He holds a PhD from Western University in Biomedical Engineering. After finishing the fellowship he went on to become a postdoctoral fellow at Sunnybrook Health Sciences Centre in Toronto. He also founded a startup, Magellan Biomedical which seeks to develop novel solutions that address clinical needs in minimally invasive therapy and diagnosis of cardiovascular diseases. In 2019 he accepted a faculty position at Ryerson University in the Department of Electrical, Computer, and Biomedical Engineering.

Professor Tavallaei has now been appointed to the new Tier 2 Canada Research Chair in Systems and Devices for Cardiovascular Interventions at Ryerson University in Toronto, Ontario. Cardiovascular diseases are the number-one cause of death globally, according to the World Health Organization. His research will generate new image-guided therapeutic and diagnostic solutions to overcome and better understand the limitations of the conventional devices employed during minimally invasive cardiovascular procedures, which are the main interventions performed to diagnose and treat cardiovascular diseases. “I believe the outcome of this research program will greatly benefit patients and health-care providers, and it will also have a great positive impact on Canada’s medical device industry,” said professor Tavallaei.

This article is from the Office of the Vice-President, Research & Innovation, Ryerson University website.

Read more